11 Stocks Making Headlines After Earnings Reports
In this article, we will take a look at the 11 stocks making headlines after earnings reports.
Ani Pharmaceuticals Inc (ANIP)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rubric Capital Management David Rosen | 376,132 | $15,131,790 | +32% | 0.65% |
| 2. | AIGH Investment Partners Orin Hirschman | 358,106 | $14,406,604 | +14% | 4.74% |
| 3. | Parkman Healthcare Partners Greg Martinez | 126,874 | $5,104,141 | +8% | 1.35% |
| 4. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 39,846 | $1,603,005 | 0.01% | |
| 5. | VGI Partners Robert M. P. Luciano | 25,000 | $1,005,750 | 0.23% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $27.69 | 7,224 | 169,650 | 2022-03-21 | Filing | ||
| $27.76 | 5,000 | 53,388 | 2022-03-21 | Filing | ||
| $27.87 | 5,000 | 393,226 | 2022-03-21 | Filing | ||
| $27.15 | 5,000 | 388,226 | 2022-03-18 | Filing | ||
| $27.65 | 5,000 | 5,000 | 2022-03-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $38.50 | 200,000 | Large Shareholder | 2,019,259 | 2022-12-01 | Filing | |
| $37.79 | 5,172 | 117,642 | 2022-08-15 | Filing | ||
| $37.04 | 12,894 | 122,814 | 2022-08-12 | Filing | ||
| $68.18 | 5,512 | Large Shareholder | 2,281,283 | 2019-08-20 | Filing | |
| $68.30 | 2,067 | Large Shareholder | 2,286,795 | 2019-08-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 1,983,605 | $79,800,427 | 0% | |
| 2. | 812,624 | $32,691,864 | 0% | |
| 3. | 527,465 | $21,219,917 | 0.08% | |
| 4. | 449,531 | $18,084,632 | 1.76% | |
| 5. | 447,987 | $18,022,517 | 0% |
News See All
ANI Pharmaceuticals Inc (ANIP) Fell Out Of Favor With Hedge Funds
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is ANI Pharmaceuticals (ANIP) A Good Stock To Buy Now?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Hedge Funds Are Selling ANI Pharmaceuticals Inc (ANIP)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Is ANI Pharmaceuticals Inc (ANIP) Going To Burn These Hedge Funds ?
Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply aren't very good.
Here is What Hedge Funds Think About ANI Pharmaceuticals Inc (ANIP)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Piled Into This Stock Right Before Its Double Digit Gains
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before the Q4 market crash that the stock market is overvalued due to a low interest rate environment that leads to companies...
Did Hedge Funds Drop The Ball On ANI Pharmaceuticals Inc (ANIP) ?
Is ANI Pharmaceuticals Inc (NASDAQ:ANIP) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research.
Hedge Funds Are Crazy About ANI Pharmaceuticals Inc (ANIP)
Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that big brokerage houses don...
Mangrove Partners: Performance, AUM, and Holdings
Mangrove Partners is among the best performing hedge funds in previous years.
Billionaire Hedge Funds
